BIO-key Intl (NASDAQ:BKYI) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.07) by 171.43 percent. This is a 58.7 percent increase over losses of $(0.46) per share from the same period last year. The company reported quarterly sales of $1.241 million which missed the analyst consensus estimate of $2.200 million by 43.59 percent. This is a 15.13 percent decrease over sales of $1.462 million the same period last year.